Previous 10 | Next 10 |
Aspira Women’s Health ( NASDAQ: AWH ), a provider of diagnostic tests for gynecologic disease, lost ~23% in the post-market trading Monday after the company announced an underwritten public offering of its common stock and warrants. AWH has selected William Blai...
AUSTIN, Texas, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced it has commenced an underwritten public offering of shares of its c...
AUSTIN, Texas, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced that it will host a key opinion leader (KOL) webinar on women’s health and...
Image source: The Motley Fool. Aspira Women's Health Inc. (NASDAQ: AWH) Q2 2022 Earnings Call Aug 10, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Aspira Women's Health Inc. (AWH) Q2 2022 Earnings Call Transcript...
Aspira Women's Health, Inc. (AWH) Q2 2022 Earnings Conference Call August 10, 2022 08:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Robert Beechey - Chief Financial Officer Ryan Phan - Chief Scientific Officer and Chief Ope...
Aspira Women’s Health press release ( NASDAQ: AWH ): Q2 GAAP EPS of -$0.07 in-line. Revenue of $2.06M (+14.4% Y/Y) misses by $0.34M . For further details see: Aspira Women’s Health GAAP EPS of -$0.07 in-line, revenue of $2.06M misses by $0.34M ...
Increased product revenue by 17% to $2.0 million; Grew OVA1plus volume by 19% to 5,411 units Entered into a research agreement with Harvard’s Dana Farber Cancer Institute, Brigham & Women’s Hospital, and Medical University of Lodz for development of a d...
AUSTIN, Texas, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced that the company will report its financial results for the second quarter ended J...
Gainers: Pliant Therapeutics ( PLRX ) +114% . Kaspien Holdings ( KSPN ) +99% . Iterum Therapeutics ( ITRM ) +83% . La Jolla Pharmaceutical Company ( LJPC ) +81% . Digital World Acquisition ( DWACW ) +51% . Volcon ( VLCN )...
AUSTIN, Texas, June 23, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the appointments of two seasoned Board members: Dr. Robert Auerbach and Ms. Ruby ...
News, Short Squeeze, Breakout and More Instantly...
Aspira Women's Health Inc. Company Name:
AWH Stock Symbol:
NASDAQ Market:
Aspira Women's Health Inc. Website:
Preliminary OvaWatch ® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuite SM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Heal...
AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that i...
AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has...